Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Holly Loux

Pediatrics Naperville, IL Medical Doctor

NPI 1215991245 CMS profile 327720

4043 S Route 59, Naperville, IL 60564

Open in the dashboard

General payments

$5,323

272 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Holly Loux of Naperville, IL is reported in the CMS Open Payments database as having received $5,323 across 272 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Pediatrics profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,043 50
2024 General $1,025 36
2023 General $940 47
2022 General $603 36
2021 General $730 44
2020 General $416 24
2019 General $566 35

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Holly Loux
  • Pediatrics median
  • Middle half of Pediatrics
  • National median

In program year 2025, general payments to Holly Loux were reported at $1,043. Among 22,296 Pediatrics profiles paid that year, the median was $97 and the middle half received between $37 and $210.

Show as a table
Year Holly Loux Pediatrics median Middle half National median
2019 $566 $86 $31–$183 $163
2020 $416 $49 $22–$110 $114
2021 $730 $68 $27–$158 $132
2022 $603 $77 $30–$173 $149
2023 $940 $88 $33–$190 $160
2024 $1,025 $94 $34–$206 $164
2025 $1,043 $97 $37–$210 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Supernus Pharmaceuticals, Inc. $752 25 payments
  2. Ironshore Pharmaceuticals Inc. $602 31 payments
  3. Corium, Inc. $583 26 payments
  4. Tris Pharma Inc $573 36 payments
  5. Merck Sharp & Dohme Corporation $344 21 payments
  6. Neos Therapeutics, LP $317 20 payments
  7. Adlon Therapeutics L.P. $302 17 payments
  8. Pfizer Inc. $238 13 payments
  9. Sobi, Inc $236 11 payments
  10. Cranial Technologies, Inc $152 12 payments
  11. Other $1,226 60 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $5,323 272 payments
Products named General payments · program years 2019–2025
  1. Azstarys $583 26 payments
  2. Qelbree Viloxazine Hydrochloride $448 7 payments
  3. JORNAY PM $331 17 payments
  4. QELBREE Psychology $304 18 payments
  5. ADHANSIA XR $302 17 payments
  6. Dyanavel XR $266 15 payments
  7. VAXELIS $265 15 payments
  8. COTEMPLA XR-ODT $241 15 payments
  9. VAXNEUVANCE $238 13 payments
  10. SYNAGIS $236 11 payments
  11. Other $3,588 207 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

272 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatrics in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record